The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Ryan Zimmerman - BTIG - Analyst
: Good morning. Thanks for taking the questions. Just wanted to start with talking about the installed base and utilization a little bit. And it continues
to grow really nicely and the procedure volumes are very encouraging to see.
And I'm just curious, Nick, if you could kind of talk about -- I mean, some of your users have been with the system for a while -- kind of how their
utilization looks on their system relative to newer users and kind of what it takes for those newer users to ramp up I think would be helpful to
understand.
And if you could also just comment on kind of -- I mean, the procedure volumes again, very encouraging. How is that trending into April and early
May?
Question: Ryan Zimmerman - BTIG - Analyst
: very encouraging -- go ahead.
Question: Ryan Zimmerman - BTIG - Analyst
: Very helpful. Thanks for taking my questions.
Question: Danielle Antalffy - SVB - Analyst
: Good morning, guys. Thanks so much for taking the question. Congrats on a really strong quarter and a strong showing at ASCRS.
Nick, I was wondering, as you think about ALLY -- thank you, guys, so much for the data on number of demos and particularly new or noncurrent
users. So as we think about that and think about the upcoming FDA approval of ALLY, how do we think about the rollout there? I spent some time
at the booth; I can see that the anticipation is high. So, I'm guessing a lot of these docs are just asking when can we get one. So help us understand
how you guys are approaching the rollout of ALLY once it's approved.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
MAY 09, 2022 / 12:30PM, LNSR.OQ - Q1 2022 LENSAR Inc Earnings Call
Question: Danielle Antalffy - SVB - Analyst
: Okay. So that was my next question. So right to think about this as 2022 will be more measured; '23, you can let the reins loose here.
Question: Danielle Antalffy - SVB - Analyst
: Sure. Okay, okay. And then when thinking about utilization, just following up on Ryan's question there, utilization on the current system versus
how we should think about utilization on ALLY. I know it hasn't launched yet, so I guess TBD, but theoretically you have to think that utilization
could move significantly higher with ALLY, given the improved efficiencies on the system.
So just how are you guys thinking about it, even theoretically or qualitatively would be helpful. Thanks so much for taking the question.
Question: Danielle Antalffy - SVB - Analyst
: It sure did. Thank you, Nick. That was so helpful. Thanks, guys.
| 
